ReviewCurrent rheumatology reviews2026
mRNAome Analysis of Whole Blood of Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Rheumatoid Arthritis.
Review in Current rheumatology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionPsoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA) are common chronic inflammatory diseases, with some clinical similarities and differences. mRNAome analysis provides a valuable approach to understand disease pathogenesis. To elucidate the underlying mechanisms of similarities and differences among these inflammatory diseases, we analyzed the commonly and specifically expressed mRNAs in the whole blood of patients with PsA, AS, and RA.
methodsRaw gene expression datasets (GSE61281, GSE25101, and GSE93272) were obtained from the Gene Expression Omnibus database and subjected to differential gene expression analysis using R program version 4.4.1. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were used to analyze gene function, biological networks, and canonical pathways.
resultsA total of 652, 78, and 246 genes were specifically expressed in the whole blood of patients with PsA, AS, and RA, respectively. Additionally, 17 commonly expressed genes were upregulated in patients with PsA, AS, and RA. The primary pathways associated with commonly expressed genes included neurodegenerative diseases, oxidative phosphorylation, reactive oxygen species, and non-alcoholic fatty liver disease. DISCUSSION: The gene expression analysis revealed both specific and common genetic signatures in the whole blood of patients with PsA, AS, and RA. Understanding these genetic patterns may provide insights into the clinical similarities and differences among these arthritic conditions and enhance our comprehension of their pathogenesis.
conclusionThis study identified distinct and shared gene expression patterns in the whole blood of patients with PsA, AS, and RA. Most of these genes are predominantly associated with oxidative phosphorylation, reactive oxygen species, ribosome function, and neurodegenerative diseases.
Indexed as
Identifiers
40917022What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.